Yuka Ikeda

1.1k total citations
35 papers, 899 citations indexed

About

Yuka Ikeda is a scholar working on Molecular Biology, Surgery and Immunology. According to data from OpenAlex, Yuka Ikeda has authored 35 papers receiving a total of 899 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 9 papers in Surgery and 8 papers in Immunology. Recurrent topics in Yuka Ikeda's work include RNA and protein synthesis mechanisms (5 papers), Infant Health and Development (3 papers) and Angiogenesis and VEGF in Cancer (3 papers). Yuka Ikeda is often cited by papers focused on RNA and protein synthesis mechanisms (5 papers), Infant Health and Development (3 papers) and Angiogenesis and VEGF in Cancer (3 papers). Yuka Ikeda collaborates with scholars based in Japan, United States and Belgium. Yuka Ikeda's co-authors include Ryuichi Morishita, Hiromi Rakugi, Yoshiharu Kaneo, Tetsuro Tanaka, Sho Morioka, Shota Yoshida, Munehisa Shimamura, Hironori Nakagami, Jun Ninomiya‐Tsuji and Kunihiro Matsumoto and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Yuka Ikeda

34 papers receiving 894 citations

Peers

Yuka Ikeda

IMMUN

CCM

SURGE

Hassan El Btaouri France

Anna L. Kiss Hungary

Yadong Zhang China

Paola Moretto Italy

Iran Rashedi Canada

Rui Guo China

Peter Vischer Germany

Ryo Matsumoto Japan

Jiyeon Jang South Korea

Hassan El Btaouri France

Yuka Ikeda

414 ×0.8

122 ×0.7

IMMUN

76 ×0.7

CCM

102 ×1.0

SURGE

154 ×1.6

Citations per year, relative to Yuka Ikeda Yuka Ikeda (= 1×) peers Hassan El Btaouri

Countries citing papers authored by Yuka Ikeda

Since Specialization

Citations

This map shows the geographic impact of Yuka Ikeda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuka Ikeda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuka Ikeda more than expected).

Fields of papers citing papers by Yuka Ikeda

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuka Ikeda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuka Ikeda. The network helps show where Yuka Ikeda may publish in the future.

Co-authorship network of co-authors of Yuka Ikeda

This figure shows the co-authorship network connecting the top 25 collaborators of Yuka Ikeda. A scholar is included among the top collaborators of Yuka Ikeda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuka Ikeda. Yuka Ikeda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ikeda, Yuka, et al.. (2024). Relevant MicroRNAs of MMPs and TIMPs with Certain Gut Microbiota Could Be Involved in the Invasiveness and Metastasis of Malignant Tumors. 1(2). 10–10. 12 indexed citations

Yoshida, Shota, Hironori Nakagami, Hiroki Hayashi, et al.. (2020). The CD153 vaccine is a senotherapeutic option for preventing the accumulation of senescent T cells in mice. Nature Communications. 11(1). 2482–2482. 106 indexed citations

Shimamura, Munehisa, Hiroki Hayashi, Yuka Ikeda, et al.. (2019). Preventative effects of the partial RANKL peptide MHP1-AcN in a mouse model of imiquimod-induced psoriasis. Scientific Reports. 9(1). 15434–15434. 15 indexed citations

Kawakami, Ryo, Yoichi Nozato, Hironori Nakagami, et al.. (2018). Development of vaccine for dyslipidemia targeted to a proprotein convertase subtilisin/kexin type 9 (PCSK9) epitope in mice. PLoS ONE. 13(2). e0191895–e0191895. 50 indexed citations

Shimamura, Munehisa, Hironori Nakagami, Hideo Shimizu, et al.. (2018). Development of a novel RANKL-based peptide, microglial healing peptide1-AcN (MHP1-AcN), for treatment of ischemic stroke. Scientific Reports. 8(1). 17770–17770. 15 indexed citations

Sanada, Fumihiro, Yoshiaki Taniyama, Rei Otsu, et al.. (2015). Gene therapy in peripheral artery disease. Expert Opinion on Biological Therapy. 15(3). 381–390. 20 indexed citations

Taniyama, Yoshiaki, Naruto Katsuragi, Fumihiro Sanada, et al.. (2015). Selective Blockade of Periostin Exon 17 Preserves Cardiac Performance in Acute Myocardial Infarction. Hypertension. 67(2). 356–361. 54 indexed citations

Ikeda, Yuka, et al.. (2014). Respiratory inhibition after crying and feeding hypoxemia in infants. The Journal of Maternal-Fetal & Neonatal Medicine. 28(18). 2234–2238. 7 indexed citations

Ikeda, Yuka, Sho Morioka, Kunihiro Matsumoto, & Jun Ninomiya‐Tsuji. (2014). TAK1 Binding Protein 2 Is Essential for Liver Protection from Stressors. PLoS ONE. 9(2). e88037–e88037. 10 indexed citations

10.

Hiraishi, Hiroyuki, Sherry L. Haller, Evangelos Papadopoulos, et al.. (2014). Essential role of eIF5-mimic protein in animal development is linked to control of ATF4 expression. Nucleic Acids Research. 42(16). 10321–10330. 26 indexed citations

11.

Sanada, Fumihiro, Yoshiaki Taniyama, Junya Azuma, et al.. (2014). Therapeutic Angiogenesis by Gene Therapy for Critical Limb Ischemia: Choice of Biological Agent. Immunology Endocrine & Metabolic Agents - Medicinal Chemistry. 14(1). 32–39. 10 indexed citations

12.

Singh, Chingakham Ranjit, Ryosuke Watanabe, Donghui Zhou, et al.. (2011). Mechanisms of translational regulation by a human eIF5-mimic protein. Nucleic Acids Research. 39(19). 8314–8328. 46 indexed citations

13.

Ohashi, Takao, Shin‐ichi Nakakita, Wataru Sumiyoshi, et al.. (2010). Structural analysis of 1,3-linked galactose-containing oligosaccharides in Schizosaccharomyces pombe mutants harboring single and multiple -galactosyltransferase genes disruptions. Glycobiology. 21(3). 340–351. 12 indexed citations

14.

Hasegawa, M., Yuka Ikeda, Mika Sakamoto, et al.. (2010). Multiple γ-glutamylation: A novel type of post-translational modification in a diapausing Artemia cyst protein. Biochemical and Biophysical Research Communications. 394(1). 36–41. 3 indexed citations

15.

Ohashi, Takao, Yuka Ikeda, Naotaka Tanaka, et al.. (2009). Theoch1Mutant ofSchizosaccharomyces pombeProduces Galactosylated Core Structures ofN-Linked Oligosaccharides. Bioscience Biotechnology and Biochemistry. 73(2). 407–414. 22 indexed citations

16.

Ikeda, Yuka, Takao Ohashi, Naotaka Tanaka, & Kaoru Takegawa. (2008). Identification and characterization of a gene required for Î±1,2-mannose extension in theO-linked glycan synthesis pathway inSchizosaccharomyces pombe. FEMS Yeast Research. 9(1). 115–125. 25 indexed citations

17.

Yamamoto, Hiroshi, Nobuhiko Nakashima, Yuka Ikeda, & Toshio Uchiumi. (2007). Binding Mode of the First Aminoacyl-tRNA in Translation Initiation Mediated by Plautia stali Intestine Virus Internal Ribosome Entry Site. Journal of Biological Chemistry. 282(11). 7770–7776. 45 indexed citations

18.

Kaneo, Yoshiharu, et al.. (2005). Pharmacokinetics and Biodisposition of Poly(vinyl alcohol) in Rats and Mice. Drug Metabolism and Pharmacokinetics. 20(6). 435–442. 60 indexed citations

19.

Shibasaki, Seiji, Mitsuyoshi Ueda, Masaaki Hirayama, et al.. (2001). Quantitative evaluation of the enhanced green fluorescent protein displayed on the cell surface of Saccharomyces cerevisiae by fluorometric and confocal laser scanning microscopic analyses. Applied Microbiology and Biotechnology. 55(4). 471–475. 75 indexed citations

20.

Ikeda, Yuka. (1994). A Case of an HLTV-I Carrier Associated with Basedow's Disease and Uveitis.. Nippon Ronen Igakkai Zasshi Japanese Journal of Geriatrics. 31(5). 415–417. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact